Related Experiment Video
Updated: Dec 23, 2025
03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.7K
COVID-19: Four Paediatric Cases in Malaysia
K C See1, S M Liew2, David C E Ng3
1Department of Paediatric, Hospital Sungai Buloh, Ministry of Health, Malaysia.
Summary
Four pediatric COVID-19 cases in Malaysia presented with mild symptoms, highlighting challenges in child quarantine and testing accuracy. Clearer guidelines are needed for managing pediatric coronavirus disease 2019.
Area of Science:
- Pediatric infectious diseases
- Virology
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) has rapidly spread globally.
- Pediatric cases of COVID-19 are less common, necessitating specific reporting.
- Understanding COVID-19 in children is crucial for disease management.
Purpose of the Study:
- To report on pediatric cases of COVID-19 in Malaysia.
- To highlight challenges in managing COVID-19 in children.
Main Methods:
- Retrospective review of four pediatric COVID-19 cases in Malaysia (up to February 2020).
- Cases involved children aged 20 months to 11 years, likely infected in China.
- Clinical presentation and management were documented.
Main Results:
- All four pediatric cases exhibited no symptoms or mild flu-like illness.
- Symptomatic management was provided; no antiviral therapy was required.
- Two key issues identified: ethical dilemma in quarantining infected children with negative-testing parents and risk of false-negative swab results.
Conclusions:
- Ethical considerations for quarantine policies in pediatric COVID-19 cases require attention.
- Diagnostic challenges, including false-negative results from oropharyngeal and nasal swabs in children, need addressing.
- Development of clearer guidelines for pediatric quarantine and testing is essential for effective infection control in COVID-19 management.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
133
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
149
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
194
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
00:52Pareto Chart
7.6K
A Pareto chart is a bar graph or a combination of both line and bar graphs. The bar lengths represent the individual values or the frequency, while the lines represent the cumulative total values. In this chart, the longest bars are arranged on the left and the shortest bars on the right, which makes it easier to read and interpret the data. It can also be called a Pareto diagram or Pareto analysis.
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
7.6K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
174
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174
01:05Single Nucleotide Polymorphisms-SNPs
17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K